Management ChangeJul 21, 2026, 04:32 PM
Alzamend Neuro Director Lynne Fahey McGrath Passes Away
AI Summary
Alzamend Neuro, Inc. announced the passing of its director, Lynne Fahey McGrath, M.P.H., Ph.D., on July 20, 2026. Dr. McGrath had been a member of the company's Board of Directors since its initial public offering in June 2021. Chairman William B. Horne issued a statement expressing deep sadness and highlighting her dedication, insights, and biopharmaceutical knowledge.
Key Highlights
- Alzamend Neuro Director Lynne Fahey McGrath, M.P.H., Ph.D., passed away on July 20, 2026.
- Dr. McGrath served on the Company's Board of Directors since its initial public offering in June 2021.
- William B. Horne, Chairman of the Board, expressed profound sadness and acknowledged her significant contributions.
Price Impact
More from ALZN